sales@businessmarketinsights.com   UK: +442030260021  , US: +16467917070  , Toll Free: 1800 121 6455
Medical Device Europe Exosome Diagnostic and Therapeutic Market...

Europe Exosome Diagnostic and Therapeutic Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Application (Diagnostic and Therapeutic); Product (Instruments, Reagents, and Software); End User (Cancer Institute, Hospitals, Diagnostic Centers, and Other End Users), and Country

TIPRE00013266 | Pages: 93 | Medical Device | Aug 2020 | Type: Regional | Status: Published

Market Introduction

This research report provides insights into Europe's exosome diagnostic and therapeutics market. The exosome is nano-vesicles that constitute proteins, DNA, and RNA. Exosomes play an essential role in aiding cell-to-cell communication in the cancer diagnosis. It lowers the body's immune function by stimulating programmed cell death of activated cytotoxic T cells, which modifies neoplasm progression within the human body. The market for exosome diagnostic and therapeutics is expected to witness massive growth due to higher precision and advantages over traditional methods of diagnosis and therapeutics.


Get more information on this report :



Market Overview and Dynamics

The Europe Exosome Diagnostic and Therapeutic  market is projected to reach US$1,04,694.72 thousand by2027 from US$ 12,524.24 thousand in 2019. The market is estimated to grow at CAGR of 32.5% from 2020 to 2027. The growth of the Europe Exosome Diagnostic and Therapeutic market is attributed to the greater precision and advantages over traditional methods of diagnosis and therapeutics, rise in research and development activities. However, the poor infrastructure and lack of expertise required for isolation of exosomes limits the growth of market in this region. Countries in Europe are expecting to witness huge challenge due to growing COVID-19. Due to outbreak of disease, healthcare industries has been affected badly. Due to growing coronavirus cases, many business related activities such as product launches and product promotion conferences has been postponed, leading to restraining the growth of the market.

Key Market Segments

Based on application, the Europe Exosome Diagnostic and Therapeutic market is segmented into diagnostic and therapeutic. In 2019, the diagnostic segment held a larger share of the market and is expected to grow at a faster rate during the forecast period.

Major Sources and Companies Listed

A few major primary and secondary sources referred to while preparing the Europe Exosome Diagnostic and Therapeutic Market report are World Health Organization, Ministry of Health and Prevention, and Ministry of Health and Family Welfare, The Food and Drug Administration, European Medical Association.

Reasons to buy the report

  • To understand the Europe Exosome Diagnostic and Therapeutic  market landscape and identify market segments that are most likely to guarantee a strong return
  • To stay ahead in comprehending the ever-changing competitive landscape of the Europe exosome diagnostic and therapeutic market
  • To efficiently plan M&A and partnership deals in the Europe exosome diagnostic and therapeutic market by identifying market segments with the most promising probable sales
  • To help take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segments in the Europe exosome diagnostic and therapeutic market
  • To obtain market revenue forecast from 2019 to 2027 in various segments of the Europe exosome diagnostic and therapeutic market

EUROPE EXOSOME DIAGNOSTIC AND THERAPEUTIC  MARKET SEGMENTATION

By Application

  • Diagnostic
  • Therapeutic

By Product

  • Instruments
  • Reagents
  • Software

By End User

  • Cancer Institutes
  • Hospitals
  • Diagnostic Centers
  • Others

By Country

  • UK
  • Germany
  • France
  • Italy
  • Spain

Company Profiles

  • Cell Guidance Systems
  • Evomic Science LLC
  • Exosome Diagnostics
  • ITH, Immune Therapy Holdings AB
  • Miltenyi Biotec
  • Norgen Biotek Corp
  • Reneuron Group Plc

1.          Introduction

1.1        Scope of the Study

1.2        The Insight Partners Research Report Guidance

1.3        Market Segmentation

1.3.1        Europe Exosome diagnostic and therapeutic Market – By Application

1.3.2        Europe Exosome diagnostic and therapeutic Market – By Product

1.3.3        Europe Exosome diagnostic and therapeutic Market – By End User

1.3.4        Europe Exosome Diagnostic and Therapeutic Market – By Country

2.          Exosome Diagnostic And Therapeutic Market – Key Takeaways

3.          Research Methodology

3.1        Coverage

3.2        Secondary Research

3.3        Primary Research

4.          Europe Exosome Diagnostic and Therapeutic Market – Market Landscape

4.1        Overview

4.2        Pest Analysis

4.2.1        Europe– PEST Analysis

5.          Europe Exosome Diagnostic and Therapeutic Market  Key Market Dynamics

5.1        Key Market Drivers

5.1.1        Greater Precision and Advantages over Traditional Methods of Diagnosis and Therapeutics

5.1.2        Rise in Research and Development Activities

5.2        Key Market Restraints

5.2.1        Poor Infrastructure and Lack of Expertise Required for Isolation of Exosomes

5.3        Key Market Opportunities

5.3.1        Growing Preference for Non-invasive and Novel Diagnostic Procedures

5.4        Future Trends

5.4.1        Automation of Exosome Isolation Process

5.5        Impact analysis

6.          Exosome Diagnostic and Therapeutic Market Analysis – By Application

6.1        Overview

6.2        Exosome Diagnostic and Therapeutic Market Share, by Application, 2019 and 2027 (%)

6.3        Diagnostic

6.3.1        Overview

6.3.2        Diagnostic: Exosome Diagnostic and Therapeutic Market– Revenue and Forecast to 2027 (US$ Thousand)

6.4        Therapeutic

6.4.1        Overview

6.4.2        Therapeutic: Exosome Diagnostic and Therapeutic Market– Revenue and Forecast to 2027 (US$ Thousand)

7.          Exosome Diagnostic and Therapeutic Market Analysis  By Product

7.1        Overview

7.2        Exosome Diagnostic and Therapeutic Market Share, by Product, 2019 and 2027, (%)

7.3        Instruments

7.3.1        Overview

7.3.2        Instruments: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (US$ Thousand)

7.4        Reagents

7.4.1        Overview

7.4.2        Reagents: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (US$ Thousand)

7.5        Software

7.5.1        Overview

7.5.2        Software: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (US$ Thousand)

8.          Exosome Diagnostic and Therapeutic Market Analysis  By End User

8.1        Overview

8.2        Exosome Diagnostic and Therapeutic Market Share, by End User, 2019 and 2027, (%)

8.3        Cancer Institutes

8.3.1        Overview

8.3.2        Cancer Institutes: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (US$ Thousand)

8.4        Hospitals

8.4.1        Overview

8.4.2        Hospitals: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (US$ Thousand)

8.5        Diagnostic Centres

8.5.1        Overview

8.5.2        Diagnostic Centres: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (US$ Thousand)

8.6        Other End User

8.6.1        Overview

8.6.2        Other End Users: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (US$ Thousand)

9.          Exosome Diagnostic and Therapeutic Market – Country Analysis

9.1        Europe: Exosome Diagnostic and Therapeutic Market

9.1.1        Overview

9.1.2        Europe: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)

9.1.3        Europe: Exosome Diagnostic and Therapeutic Market, by Application, 2018–2027 (USD Thousands)

9.1.4        Europe: Exosome Diagnostic and Therapeutic Market, by Product, 2018–2027 (USD Thousand)

9.1.5        Europe: Exosome Diagnostic and Therapeutic Market, by End User, 2018–2027 (USD Thousand)

9.1.6        Europe: Exosome Diagnostic and Therapeutic Market, by Country, 2019& 2027 (%)

9.1.7        Germany: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)

9.1.7.1         Germany: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)

9.1.8        Germany: Exosome Diagnostic and Therapeutic Market, by Application, 2018–2027 (USD Thousand)

9.1.9        Germany: Exosome Diagnostic and Therapeutic Market, by Product, 2018–2027 (USD Thousand)

9.1.10     Germany: Exosome Diagnostic and Therapeutic Market, by End User, 2018–2027 (USD Thousand)

9.1.11     France: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)

9.1.11.1       France: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)

9.1.12     France: Exosome Diagnostic and Therapeutic Market, by Application, 2018–2027 (USD Thousand)

9.1.13     France: Exosome Diagnostic and Therapeutic Market, by Product, 2018–2027 (USD Thousand)

9.1.14     France: Exosome Diagnostic and Therapeutic Market, by End User, 2018–2027 (USD Thousand)

9.1.15     UK: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)

9.1.15.1       UK: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)

9.1.16     UK: Exosome Diagnostic and Therapeutic Market, by Application, 2018–2027 (USD Thousand)

9.1.17     UK: Exosome Diagnostic and Therapeutic Market, by Product, 2018–2027 (USD Thousand)

9.1.18     UK: Exosome Diagnostic and Therapeutic Market, by End User, 2018–2027 (USD Thousand)

9.1.19     Italy: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)

9.1.19.1       Italy: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)

9.1.20     Italy: Exosome Diagnostic and Therapeutic Market, by Application, 2018–2027 (USD Thousand)

9.1.21     Italy: Exosome Diagnostic and Therapeutic Market, by Product, 2018–2027 (USD Thousand)

9.1.22     Italy: Exosome Diagnostic and Therapeutic Market, by End User, 2018–2027 (USD Thousand)

9.1.23     Spain: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)

9.1.23.1       Spain: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)

9.1.24     Spain: Exosome Diagnostic and Therapeutic Market, by Application, 2018–2027 (USD Thousand)

9.1.25     Spain: Exosome Diagnostic and Therapeutic Market, by Product, 2018–2027 (USD Thousand)

9.1.26     Spain: Exosome Diagnostic and Therapeutic Market, by End User, 2018–2027 (USD Thousand)

10.       IMPACT OF COVID-19 PANDEMIC ON EUROPE EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET

10.1     Europe: Impact assessment of COVID-19 Pandemic

11.       COMPANY PROFILES

11.1     Cell Guidance Systems

11.1.1     Key Facts

11.1.2     Business Description

11.1.3     Products and Services

11.1.4     Financial Overview

11.1.5     SWOT Analysis

11.1.6     Key Developments

11.2     Evomic Science LLC

11.2.1     Key Facts

11.2.2     Business Description

11.2.3     Products and Services

11.2.4     Financial Overview

11.2.5     SWOT Analysis

11.2.6     Key Developments

11.3     Norgen Biotek Corp

11.3.1     Key Facts

11.3.2     Business Description

11.3.3     Products and Services

11.3.4     Financial Overview

11.3.5     SWOT Analysis

11.3.6     Key Developments

11.4     Miltenyi Biotec

11.4.1     Key Facts

11.4.2     Business Description

11.4.3     Products and Services

11.4.4     Financial Overview

11.4.5     SWOT Analysis

11.4.6     Key Developments

11.5     RENEURON GROUP PLC

11.5.1     Key Facts

11.5.2     Business Description

11.5.3     Products and Services

11.5.4     Financial Overview

11.5.5     SWOT Analysis

11.5.6     Key Developments

11.6     ITH, Immune Therapy Holdings AB

11.6.1     Key Facts

11.6.2     Business Description

11.6.3     Products and Services

11.6.4     Financial Overview

11.6.5     SWOT Analysis

11.6.6     Key Developments

11.7     EXOSOME DIAGNOSTICS

11.7.1     Key Facts

11.7.2     Business Description

11.7.3     Products and Services

11.7.4     Financial Overview

11.7.5     SWOT Analysis

11.7.6     Key Developments

12.       Appendix

12.1     About The Insight Partners

12.2     Glossary of Terms

LIST OF TABLES

Table 1.            Europe Exosome Diagnostic and Therapeutic Market, by Application– Revenue and Forecast to 2027 (USD Thousands)

Table 2.            Europe Exosome Diagnostic and Therapeutic Market, by Product – Revenue and Forecast to 2027 (USD Thousand)

Table 3.            Europe Exosome Diagnostic and Therapeutic Market, by End User – Revenue and Forecast to 2027 (USD Thousand)

Table 4.            Germany Exosome Diagnostic and Therapeutic Market, by Application– Revenue and Forecast to 2027 (USD Thousand)

Table 5.            Germany Exosome Diagnostic and Therapeutic Market, by Product – Revenue and Forecast to 2027 (USD Thousand)

Table 6.            Germany Exosome Diagnostic and Therapeutic Market, by End User – Revenue and Forecast to 2027 (USD Thousand)

Table 7.            France Exosome Diagnostic and Therapeutic Market, by Application– Revenue and Forecast to 2027 (USD Thousand)

Table 8.            France Exosome Diagnostic and Therapeutic Market, by Product – Revenue and Forecast to 2027 (USD Thousand)

Table 9.            France Exosome Diagnostic and Therapeutic Market, by End User – Revenue and Forecast to 2027 (USD Thousand)

Table 10.         UK Exosome Diagnostic and Therapeutic Market, by Application– Revenue and Forecast to 2027 (USD Thousand)

Table 11.         UK Exosome Diagnostic and Therapeutic Market, by Product – Revenue and Forecast to 2027 (USD Thousand)

Table 12.         UK Exosome Diagnostic and Therapeutic Market, by End User – Revenue and Forecast to 2027 (USD Thousand)

Table 13.         Italy Exosome Diagnostic and Therapeutic Market, by Application– Revenue and Forecast to 2027 (USD Thousand)

Table 14.         Italy Exosome Diagnostic and Therapeutic Market, by Product – Revenue and Forecast to 2027 (USD Thousand)

Table 15.         Italy Exosome Diagnostic and Therapeutic Market, by End User – Revenue and Forecast to 2027 (USD Thousand)

Table 16.         Spain Exosome Diagnostic and Therapeutic Market, by Application– Revenue and Forecast to 2027 (USD Thousand)

Table 17.         Spain Exosome Diagnostic and Therapeutic Market, by Product – Revenue and Forecast to 2027 (USD Thousand)

Table 18.         Spain Exosome Diagnostic and Therapeutic Market, by End User – Revenue and Forecast to 2027 (USD Thousand)

Table 19.         Glossary of Terms, Exosome diagnostic and treatment market

LIST OF FIGURES

Figure 1.          Exosome Diagnostic and Therapeutic Market Segmentation

Figure 2.          Exosome Diagnostic and Therapeutic Segmentation, By Region

Figure 3.          Europe Exosome Diagnostic and Therapeutic Market Overview

Figure 4.          Diagnostics Held Largest Share Of Application Segment In Exosome diagnostic and Therapeutic Market

Figure 5.          Germany Is Expected to Show Remarkable Growth during the Forecast Period

Figure 6.          Europe PEST Analysis

Figure 7.          Exosome diagnostic and therapeutic market impact analysis of driver and restraints

Figure 8.          Exosome Diagnostic and Therapeutic Market Share, by Application, 2019 and 2027 (%)

Figure 9.          Diagnostic: Exosome Diagnostic and Therapeutic Market– Revenue and Forecast to 2027 (US$ Thousand)

Figure 10.        Therapeutic: Exosome Diagnostic and Therapeutic Market– Revenue and Forecast to 2027 (US$ Thousand)

Figure 11.        Exosome Diagnostic and Therapeutic Market Share, by Product, 2019 and 2027 (%)

Figure 12.        Instruments: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (US$ Thousand)

Figure 13.        Reagents: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (US$ Thousand)

Figure 14.        Software: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (US$ Thousand)

Figure 15.        Exosome Diagnostic and Therapeutic Market Share, by End User, 2019 and 2027 (%)

Figure 16.        Cancer Institutes: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (US$ Thousand)

Figure 17.        Hospitals: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (US$ Thousand)

Figure 18.        Diagnostic Centers: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (US$ Thousand)

Figure 19.        Other End Users: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (US$ Thousand)

Figure 20.        Europe: Exosome Diagnostic and Therapeutic Market, by Key Country – Revenue (2019) (USD Thousand)

Figure 21.        Europe Exosome Diagnostic and Therapeutic Market Revenue and Forecast to 2027 (USD Thousands)

Figure 22.        Germany: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)

Figure 23.        France: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)

Figure 24.        UK: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)

Figure 25.        Italy: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)

Figure 26.        Spain: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)

Figure 27.        IMPACT OF COVID-19 PANDEMIC IN EUROPE COUNTRY MARKETS

  1. Cell Guidance Systems
  2. Evomic Science LLC
  3. Exosome Diagnostics
  4. ITH, Immune Therapy Holdings AB
  5. Miltenyi Biotec
  6. Norgen Biotek Corp
  7. Reneuron Group Plc
  • To understand the Europe Exosome Diagnostic and Therapeutic  market landscape and identify market segments that are most likely to guarantee a strong return.

  • To stay ahead in comprehending the ever-changing competitive landscape of the Europe exosome diagnostic and therapeutic market.

  • To efficiently plan M&A and partnership deals in the Europe exosome diagnostic and therapeutic market by identifying market segments with the most promising probable sales.

  • To help take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segments in the Europe exosome diagnostic and therapeutic market.

  • To obtain market revenue forecast from 2019 to 2027 in various segments of the Europe exosome diagnostic and therapeutic market.
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports
Report Name Published Date
Europe Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software and Serv.. May 2022
Europe Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Electric P.. May 2022
Europe In-Office Teeth Whitening Products Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Double-Syringe Mixing Configurat.. May 2022
Purchase Options
Single User License
$3000
$1800
Site License
$4000
$2400
Enterprise License
$5000
$3000
GET FREE SAMPLE PDF
Inquire before Buying Inquire for Discount
Subscription Member Price: FREE
Get Subscription